Ann Hypertens | Volume 1, Issue 1 | Research Article | Open Access

Pulmonary Hypertension in Hemodialysis Patients: The Missed Diagnosis

Evgeny Sklarenko¹, Nakhoul Rola², Anaam Hnut³, Nakhoul Farid³ and Evgeny Farber^3*

¹Division of Radiology, Baruch Padeh Poriya Medical Center, Israel
²Department of Medicine, University of Szeged, Israel
³Division of Nephrology & Hypertension, The Baruch Padeh Poriya Medical Center, Israel

^*Correspondance to: Evgeny Farber 

Fulltext PDF

Abstract

Chronic Kidney Disease (CKD) is a common health problem worldwide. Cardiovascular disease is the most common cause of morbidity and mortality in CKD. Pulmonary Hypertension (PHT) is a missed cardiovascular complication of CKD, especially in End-Stage Renal Disease (ESRD). The prevalence of PHT in patients with ESRD ranges from 27% to 58%. Patients with advanced CKD have a prevalence of PHT that is lesser than that in patients with ESRD, ranging from 8% to 39%. PHT is an independent predictor of increased morbidity/mortality in patients with CKD and hemodialysis.

Citation:

Sklarenko E, Rola N, Hnut A, Farid N, Farber E. Pulmonary Hypertension in Hemodialysis Patients: The Missed Diagnosis. Ann Hypertens. 2018;1(1):1004.